STRATEGIC ALLIANCES

Oncolix has acquired its technologies from the Greenville Hospital System (GHS), who receives a small management fee to cover the company's administrative costs. A substantial discount on fees relating to clinical trials conducted at GHS’s clinical trial unit is available to Oncolix.

Oncolix has chosen BioVectra, Inc. to perform the manufacturing of Prolanta. BioVectra is the largest Canadian company manufacturing both large and small-molecule Advanced Pharmaceutical Ingredients (API's), advanced intermediates, and cGMP bioprocessing reagents. With 40 years experience in serving the pharmaceutical and biopharmaceutical industries, clients range from small drug development entities to many of the world's largest multinational health care companies.

Oncolix is a member of BIO and BioHouston.
BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BioHouston, Inc. is a non-profit corporation founded by Houston-region academic/research institutions.

Oncolix welcomes interest in developing a technical or financial partnership with both public and private entities that are symbiotic and will allow Prolanta™ to reach the market. Contact us today.